Tugal-Tutkun Ilknur, Onal Sumru, Altan-Yaycioglu Rana, Huseyin Altunbas Hasan, Urgancioglu Meri
Department of Ophthalmology, Istanbul University, Istanbul Faculty of Medicine, 34390 Capa Istanbul, Turkey.
Am J Ophthalmol. 2004 Sep;138(3):373-80. doi: 10.1016/j.ajo.2004.03.022.
We aimed to describe the demographic and clinical features, ocular manifestations, complications, visual prognosis, and treatment in a large population of Turkish patients with Behçet uveitis. We also aimed to compare visual prognosis between male and female sex and between patients who presented before and after 1990.
Observational case series.
A retrospective study of 880 consecutive patients (1,567 eyes) with Behçet uveitis seen at the Uveitis Service, Department of Ophthalmology, Istanbul Faculty of Medicine, Istanbul University, from 1980 to 1998. All patients met the classification criteria of the International Study Group for Behçet's Disease. Information on the patient's sex, age at onset of uveitis, ocular features, ocular complications, visual acuity, and systemic treatment was collected.
Five hundred ninety-nine patients (68%) were male and 281 (32%) were female. The mean age at onset of uveitis was 28.5 years in male and 30 years in female patients. Ocular involvement was bilateral in 78.1% and unilateral in 21.9% of the patients. Panuveitis was the most common form in both sexes. Fundus lesions as well as sight-threatening complications were more common in males. At the beginning of the follow-up, potential visual acuity was 0.1 or less in 30.9% of eyes in males and 24.2% of eyes in females. Kaplan-Meier survival analysis estimated the risks of losing useful vision (>0.1) at 5 and 10 years for males and females as 21% vs 10% and 30% vs 17%, respectively. Male patients who presented in the 1990s had a significantly lower risk of losing vision compared with male patients who presented in the 1980s.
Behçet uveitis starts frequently around the end of the third decade and has a male predominance. The disease is more severe and the risk of losing useful vision is higher in males than in females. However, this risk has been significantly reduced in the 1990s.
我们旨在描述大量土耳其白塞氏葡萄膜炎患者的人口统计学和临床特征、眼部表现、并发症、视力预后及治疗情况。我们还旨在比较男性和女性患者之间以及1990年之前和之后就诊患者之间的视力预后。
观察性病例系列研究。
对1980年至1998年期间在伊斯坦布尔大学伊斯坦布尔医学院眼科葡萄膜炎门诊连续就诊的880例(1567只眼)白塞氏葡萄膜炎患者进行回顾性研究。所有患者均符合国际白塞氏病研究组的分类标准。收集患者的性别、葡萄膜炎发病年龄、眼部特征、眼部并发症、视力及全身治疗等信息。
599例(68%)患者为男性,281例(32%)为女性。男性葡萄膜炎发病的平均年龄为28.5岁,女性为30岁。78.1%的患者眼部受累为双侧,21.9%为单侧。全葡萄膜炎是两性中最常见的形式。男性患者的眼底病变以及威胁视力的并发症更为常见。随访开始时,男性30.9%的患眼和女性24.2%的患眼最佳矫正视力为0.1或更低。Kaplan-Meier生存分析估计,男性和女性在5年和10年时丧失有用视力(>0.1)的风险分别为21%对10%和30%对17%。20世纪90年代就诊的男性患者与80年代就诊的男性患者相比,视力丧失风险显著降低。
白塞氏葡萄膜炎通常在第三个十年末发病,男性居多。该疾病在男性中比女性更严重,丧失有用视力的风险更高。然而,在20世纪90年代,这种风险已显著降低。